Cargando…

GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry

Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSP...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartmann, Jessica, Thalheimer, Frederic B., Höpfner, Felix, Kerzel, Thomas, Khodosevich, Konstantin, García-González, Diego, Monyer, Hannah, Diester, Ilka, Büning, Hildegard, Carette, Jan E., Fries, Pascal, Buchholz, Christian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706527/
https://www.ncbi.nlm.nih.gov/pubmed/31463334
http://dx.doi.org/10.1016/j.omtm.2019.07.004
_version_ 1783445713993072640
author Hartmann, Jessica
Thalheimer, Frederic B.
Höpfner, Felix
Kerzel, Thomas
Khodosevich, Konstantin
García-González, Diego
Monyer, Hannah
Diester, Ilka
Büning, Hildegard
Carette, Jan E.
Fries, Pascal
Buchholz, Christian J.
author_facet Hartmann, Jessica
Thalheimer, Frederic B.
Höpfner, Felix
Kerzel, Thomas
Khodosevich, Konstantin
García-González, Diego
Monyer, Hannah
Diester, Ilka
Büning, Hildegard
Carette, Jan E.
Fries, Pascal
Buchholz, Christian J.
author_sort Hartmann, Jessica
collection PubMed
description Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90% of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential.
format Online
Article
Text
id pubmed-6706527
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-67065272019-08-28 GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry Hartmann, Jessica Thalheimer, Frederic B. Höpfner, Felix Kerzel, Thomas Khodosevich, Konstantin García-González, Diego Monyer, Hannah Diester, Ilka Büning, Hildegard Carette, Jan E. Fries, Pascal Buchholz, Christian J. Mol Ther Methods Clin Dev Article Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90% of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential. American Society of Gene & Cell Therapy 2019-07-23 /pmc/articles/PMC6706527/ /pubmed/31463334 http://dx.doi.org/10.1016/j.omtm.2019.07.004 Text en © 2019 Paul-Ehrlich-Institut http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Hartmann, Jessica
Thalheimer, Frederic B.
Höpfner, Felix
Kerzel, Thomas
Khodosevich, Konstantin
García-González, Diego
Monyer, Hannah
Diester, Ilka
Büning, Hildegard
Carette, Jan E.
Fries, Pascal
Buchholz, Christian J.
GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
title GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
title_full GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
title_fullStr GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
title_full_unstemmed GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
title_short GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
title_sort glua4-targeted aav vectors deliver genes selectively to interneurons while relying on the aav receptor for entry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706527/
https://www.ncbi.nlm.nih.gov/pubmed/31463334
http://dx.doi.org/10.1016/j.omtm.2019.07.004
work_keys_str_mv AT hartmannjessica glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT thalheimerfredericb glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT hopfnerfelix glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT kerzelthomas glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT khodosevichkonstantin glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT garciagonzalezdiego glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT monyerhannah glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT diesterilka glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT buninghildegard glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT carettejane glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT friespascal glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry
AT buchholzchristianj glua4targetedaavvectorsdelivergenesselectivelytointerneuronswhilerelyingontheaavreceptorforentry